RU2407522C2 - Болеутоляющие композиции n,2,3-триметил-2-изопропилбутамида местного действия и способы их применения - Google Patents

Болеутоляющие композиции n,2,3-триметил-2-изопропилбутамида местного действия и способы их применения Download PDF

Info

Publication number
RU2407522C2
RU2407522C2 RU2008117760/15A RU2008117760A RU2407522C2 RU 2407522 C2 RU2407522 C2 RU 2407522C2 RU 2008117760/15 A RU2008117760/15 A RU 2008117760/15A RU 2008117760 A RU2008117760 A RU 2008117760A RU 2407522 C2 RU2407522 C2 RU 2407522C2
Authority
RU
Russia
Prior art keywords
pain
composition
topical
trimethyl
compositions
Prior art date
Application number
RU2008117760/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2008117760A (ru
Inventor
Ютаро СУДО (US)
Ютаро СУДО
Юдзи МАТИДА (JP)
Юдзи МАТИДА
Сейитиро КАВАБАТА (JP)
Сейитиро КАВАБАТА
Original Assignee
ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. filed Critical ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК.
Publication of RU2008117760A publication Critical patent/RU2008117760A/ru
Application granted granted Critical
Publication of RU2407522C2 publication Critical patent/RU2407522C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
RU2008117760/15A 2005-10-24 2006-10-16 Болеутоляющие композиции n,2,3-триметил-2-изопропилбутамида местного действия и способы их применения RU2407522C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72984405P 2005-10-24 2005-10-24
US60/729,844 2005-10-24

Publications (2)

Publication Number Publication Date
RU2008117760A RU2008117760A (ru) 2009-12-10
RU2407522C2 true RU2407522C2 (ru) 2010-12-27

Family

ID=37968368

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008117760/15A RU2407522C2 (ru) 2005-10-24 2006-10-16 Болеутоляющие композиции n,2,3-триметил-2-изопропилбутамида местного действия и способы их применения

Country Status (15)

Country Link
US (1) US20070093555A1 (enExample)
EP (1) EP1940377A4 (enExample)
JP (2) JP5128483B2 (enExample)
KR (1) KR20080035637A (enExample)
CN (1) CN101534805A (enExample)
AR (1) AR058141A1 (enExample)
AU (1) AU2006306563B2 (enExample)
BR (1) BRPI0613067A2 (enExample)
CA (1) CA2614345C (enExample)
MX (1) MX2008000486A (enExample)
NZ (1) NZ564014A (enExample)
RU (1) RU2407522C2 (enExample)
TW (1) TWI372047B (enExample)
WO (1) WO2007050369A2 (enExample)
ZA (1) ZA200711041B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080035637A (ko) * 2005-10-24 2008-04-23 테이코쿠 팔마 유에스에이, 인코포레이티드 엔,2,3-트리메틸-2-이소프로필부타미드의 국소 통증 경감조성물 및 그의 사용 방법
WO2011133177A1 (en) * 2010-04-21 2011-10-27 Teikoku Pharma Usa, Inc. Local anesthetic emulsion compositions and methods of making and using the same
TWI704933B (zh) 2013-10-07 2020-09-21 美商帝國製藥美國股份有限公司 右美托咪啶經皮輸送裝置及使用其之方法
KR101831290B1 (ko) 2013-10-07 2018-02-22 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 조성물을 사용하여 주의력 결핍 과잉행동 장애, 불안 및 불면증을 치료하기 위한 방법 및 조성물
KR101891185B1 (ko) 2013-10-07 2018-08-24 테이코쿠 팔마 유에스에이, 인코포레이티드 비진정량의 덱스메데토미딘의 경피 전달을 위한 방법 및 조성물
US20160158393A1 (en) * 2014-02-21 2016-06-09 Avadim Technologies, Inc. Method for Improving Health Outcomes
CA2939940C (en) 2014-02-21 2023-10-03 Avadim Technologies, Inc. Method for maintenance of urethral catheters
CA3143518A1 (en) 2019-06-12 2020-12-17 Avadim Health Ip, Inc. Compositions and methods for the antiseptic cleansing and biofilms treatment of mammalian tissue
WO2020257650A1 (en) * 2019-06-19 2020-12-24 Ganio Carl Formulations using lithium to treat gout arthropathy
KR102621024B1 (ko) * 2023-09-12 2024-01-05 (주)진코스텍 심미감 및 피부 흡수력이 개선된 하이드로겔 패치

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230688A (en) * 1972-04-18 1980-10-28 Wilkinson Sword Limited Acyclic carboxamides having a physiological cooling effect
US5853768A (en) * 1995-03-01 1998-12-29 Altadonna; James Topical preparation and method for pain relief
US20010032645A1 (en) * 1997-01-29 2001-10-25 Cronk Peter J. Adhesively applied external nasal strips and dilators containing medications and fragrances

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH10359A (en) 1971-02-04 1977-01-05 Wilkinson Sword Ltd N-substituted-p-methane-3-carboxamides having physiological cooling activity and compositions containing them
US4193936A (en) 1971-02-04 1980-03-18 Wilkinson Sword Limited N-substituted paramenthane carboxamides
US4150052A (en) * 1971-02-04 1979-04-17 Wilkinson Sword Limited N-substituted paramenthane carboxamides
US4060091A (en) 1972-01-28 1977-11-29 Wilkinson Sword Limited Tobacco and tobacco-containing manufactures containing an ingredient having physiological cooling activity
US4059118A (en) 1972-01-28 1977-11-22 Wilkinson Sword Limited Tobacco and tobacco-containing manufactures containing an ingredient having physiological cooling activity
US4033994A (en) * 1972-01-28 1977-07-05 Wilkinson Sword Limited Substituted p-menthanes
US4153679A (en) 1972-04-18 1979-05-08 Wilkinson Sword Limited Acyclic carboxamides having a physiological cooling effect
CA1027347A (en) 1972-07-20 1978-03-07 David G. Rowsell Compounds having a physiological cooling effect and compositions containing them
BE802469A (fr) * 1972-07-20 1974-01-18 Wilkinson Sword Ltd Perfectionnements apportes et/ou relatifs a des composes exercant un effet refrigerant physiologique et compositions contenant ceux-ci
GB1434728A (en) * 1972-09-27 1976-05-05 Wilkinson Sword Ltd Compositions and articles containing phospine oxides having a physiological cooling effect and phosphine oxides for use therein
US4070449A (en) * 1972-10-24 1978-01-24 Wilkinson Sword Limited Compounds having a physiological cooling effect and compositions containing them
US4034109A (en) * 1973-01-18 1977-07-05 Wilkinson Sword Limited Compounds having a physiological cooling effect and compositions containing them
US4296093A (en) * 1973-04-16 1981-10-20 Wilkinson Sword Limited Cyclic carboxamides having a physiological cooling effect
US4172887A (en) * 1973-11-30 1979-10-30 L'oreal Hair conditioning compositions containing crosslinked polyaminopolyamides
JPS5888334A (ja) * 1981-11-20 1983-05-26 Takasago Corp ３−ｌ−メントキシプロパン−１、２−ジオ−ル
US5120544A (en) 1989-06-19 1992-06-09 Henley International, Inc. Crosslinked hydrogel and method for making same
US5270358A (en) 1989-12-28 1993-12-14 Minnesota Mining And Manufacturing Company Composite of a disperesed gel in an adhesive matrix
US5148804A (en) * 1990-06-28 1992-09-22 Hill Dennis M Device, system, and methods for applying cryotherapy
JP3115625B2 (ja) 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
DE4110973A1 (de) * 1991-04-05 1992-10-08 Haarmann & Reimer Gmbh Mittel mit physiologischem kuehleffekt und fuer diese mittel geeignete wirksame verbindungen
US5160328A (en) 1991-08-07 1992-11-03 Ndm Acquisition Corp. Hydrogel bandage
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
ES2105293T3 (es) * 1992-06-17 1997-10-16 Procter & Gamble Composiciones refrescantes con efecto irritante reducido.
CA2160874C (en) * 1993-04-30 1999-05-11 William Fletcher Beck Nasal aromatic releasing compositions
US5760085A (en) * 1993-04-30 1998-06-02 The Procter & Gamble Company Topical aromatic releasing compositions
NZ250994A (en) 1993-05-27 1995-09-26 Ndm Acquisition Corp Wound dressing comprising a hydrogel layer bound to a porous backing layer which is bound to a thin film layer by adhesive
US5423737A (en) 1993-05-27 1995-06-13 New Dimensions In Medicine, Inc. Transparent hydrogel wound dressing with release tab
JP2978043B2 (ja) * 1993-09-16 1999-11-15 高砂香料工業株式会社 （２ｓ）−３−｛（１ｒ，２ｓ，５ｒ）−［ ５−メチル−２−（１−メチルエチル）シクロヘキシル ］オキシ｝−１，２−プロパンジオール，その製造方法および用途
US5407665A (en) * 1993-12-22 1995-04-18 The Procter & Gamble Company Ethanol substitutes
US5536263A (en) 1994-03-30 1996-07-16 Lectec Corporation Non-occulusive adhesive patch for applying medication to the skin
JP3241542B2 (ja) * 1994-07-29 2001-12-25 高砂香料工業株式会社 （−）−ｎ−イソプレゴールの精製方法及びその方法で得られた（−）−ｎ−イソプレゴールを含有するシトラス系香料組成物
KR100209469B1 (ko) * 1994-10-05 1999-07-15 나까도미 히로다카 N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형 제제
DE69625549T2 (de) * 1995-06-27 2003-05-15 Kao Corp., Tokio/Tokyo Pflaster mit wasserlöslicher Klebeschicht
US6039940A (en) 1996-10-28 2000-03-21 Ballard Medical Products Inherently antimicrobial quaternary amine hydrogel wound dressings
US6244265B1 (en) * 1997-01-29 2001-06-12 Peter J. Cronk Adhesively applied external nasal strips and dilators containing medications and fragrances
WO1999007342A1 (en) * 1997-08-11 1999-02-18 Alza Corporation Prolonged release active agent dosage form adapted for gastric retention
US6455080B1 (en) * 1997-12-29 2002-09-24 Wm. Wrigley Jr., Company Chewing gum containing controlled release acyclic carboxamide and method of making
US20020013304A1 (en) * 1997-10-28 2002-01-31 Wilson Leland F. As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness
JP3450680B2 (ja) 1997-10-28 2003-09-29 高砂香料工業株式会社 パラ−メンタン−３，８−ジオールの製造方法
EP1034161B2 (fr) * 1997-11-27 2006-03-15 Firmenich Sa Nouveaux composes derives du menthol et leur utilisation en tant qu'agent rafraichissant
JP4017758B2 (ja) * 1998-08-04 2007-12-05 高砂香料工業株式会社 冷感剤組成物
US6656456B2 (en) * 1998-11-23 2003-12-02 The Procter & Gamble Company Skin deodorizing compositions
US6183766B1 (en) * 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
EP1541039B1 (en) 1999-03-31 2008-01-02 Firmenich Sa Flavour composition comprising cubebol and a further refreshing agent
US6267974B1 (en) * 1999-04-16 2001-07-31 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Cosmetic compositions with sensate mixtures based on isopulegol
US6348212B2 (en) 1999-05-18 2002-02-19 Lectec Corporation Treating traumatic burns or blisters of the skin
US6455065B1 (en) 1999-05-18 2002-09-24 Lectec Corporation Therapeutic method for treating acne or isolated pimples and adhesive patch therefor
US6296869B1 (en) 1999-07-30 2001-10-02 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Adhesive cosmetic patch containing alpha or beta hydroxy acids
EP1217975A1 (en) * 1999-09-08 2002-07-03 Watson Pharmaceuticals, Inc. Using quaternary ammonium salts for transdermal drug delivery
EP1227788B1 (en) 1999-11-12 2010-08-11 The Procter & Gamble Company Oral compositions containing stannous ions
US6677391B1 (en) 1999-12-08 2004-01-13 The Procter & Gamble Company Tartar control denture adhesive compositions
ATE380474T1 (de) * 2000-05-23 2007-12-15 Nestle Sa Verwendung von alpha-ketoenaminderivaten als kühlende mittel
AU2001268451A1 (en) * 2000-06-13 2001-12-24 Fd Management, Inc. Cosmetic composition for stressed skin under extreme conditions
US6497859B1 (en) 2000-11-17 2002-12-24 Noville Inc. Cooling agents, pharmaceutical compositions having cooling agents and processes for making and using same
US6391886B1 (en) * 2000-12-04 2002-05-21 The Procter & Gamble Company Oral compositions having improved consumer aesthetics
US20020143047A1 (en) * 2001-01-05 2002-10-03 Galer Bradley S. Methods for treating indomethacin responsive headaches
US6761900B2 (en) * 2001-03-12 2004-07-13 Teikoku Pharma Usa, Inc. Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
US6514484B2 (en) 2001-03-19 2003-02-04 The Procter & Gamble Company Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier
EP1245240A1 (en) 2001-03-30 2002-10-02 The Procter & Gamble Company Skin-compatible hydrogel adhesives and personal care products containing them
CN100408016C (zh) 2001-06-25 2008-08-06 宝洁公司 口腔组合物
US20030175328A1 (en) * 2002-03-06 2003-09-18 Adi Shefer Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
JP2004059474A (ja) 2002-07-26 2004-02-26 T Hasegawa Co Ltd ｐ−メンタン誘導体およびこれを含有する冷感剤
GB0221697D0 (en) 2002-09-18 2002-10-30 Unilever Plc Novel compouds and their uses
GB0315974D0 (en) 2003-07-08 2003-08-13 Coolanalgesia Ltd Cooling device for pain relief
WO2005060550A2 (en) * 2003-12-11 2005-07-07 Teikoku Pharma Usa, Inc. Methods and compositions for treating skin wounds
US7482378B2 (en) * 2004-05-28 2009-01-27 Millenium Specialty Chemicals, Inc. Physiological cooling compositions
PL1833443T3 (pl) * 2005-01-04 2012-04-30 Teikoku Pharma Usa Inc Miejscowy preparat chłodzący w postaci plastra
US20070259354A1 (en) * 2005-10-11 2007-11-08 Senomyx, Inc. Optimized trpm8 nucleic acid sequences and their use in cell based assays and test kits to identify trpm8 modulators
KR20080035637A (ko) * 2005-10-24 2008-04-23 테이코쿠 팔마 유에스에이, 인코포레이티드 엔,2,3-트리메틸-2-이소프로필부타미드의 국소 통증 경감조성물 및 그의 사용 방법
US20070185237A1 (en) * 2005-11-09 2007-08-09 Jayanth Rajaiah Denture adhesive articles

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230688A (en) * 1972-04-18 1980-10-28 Wilkinson Sword Limited Acyclic carboxamides having a physiological cooling effect
US5853768A (en) * 1995-03-01 1998-12-29 Altadonna; James Topical preparation and method for pain relief
US20010032645A1 (en) * 1997-01-29 2001-10-25 Cronk Peter J. Adhesively applied external nasal strips and dilators containing medications and fragrances

Also Published As

Publication number Publication date
AR058141A1 (es) 2008-01-23
KR20080035637A (ko) 2008-04-23
CA2614345C (en) 2013-01-08
CA2614345A1 (en) 2007-05-03
AU2006306563A1 (en) 2007-05-03
AU2006306563B2 (en) 2009-10-01
ZA200711041B (en) 2009-08-26
TW200731965A (en) 2007-09-01
JP2012197301A (ja) 2012-10-18
JP5128483B2 (ja) 2013-01-23
WO2007050369A3 (en) 2009-04-30
EP1940377A2 (en) 2008-07-09
JP2009515829A (ja) 2009-04-16
RU2008117760A (ru) 2009-12-10
WO2007050369A2 (en) 2007-05-03
TWI372047B (en) 2012-09-11
NZ564014A (en) 2011-10-28
US20070093555A1 (en) 2007-04-26
BRPI0613067A2 (pt) 2010-12-21
CN101534805A (zh) 2009-09-16
EP1940377A4 (en) 2010-12-08
JP5508477B2 (ja) 2014-05-28
MX2008000486A (es) 2008-03-07

Similar Documents

Publication Publication Date Title
JP5508477B2 (ja) Ｎ，２，３−トリメチル−２−イソプロピルブタナミドの局所用疼痛緩和用組成物並びにその使用法
US6528076B2 (en) Topical compositions and methods for treating pain
Jarit et al. The effects of home interferential therapy on post-operative pain, edema, and range of motion of the knee
Gatlin et al. When medication is not enough: nonpharmacologic management of pain.
US20080069903A1 (en) Electrical producing creams
US8821921B2 (en) Vitamin D3 for the transdermal treatment of pain and inflammation
Sharma et al. Protocol based management of common sports injuries by integrated approach of Sandhi Marmabhighata-An open labeled clinical trial
US9186334B2 (en) Heat assisted lidocaine and tetracaine for transdermal analgesia
Brosseau et al. Efficacy of transcutaneous electrical nerve stimulation for osteoarthritis of the lower extremities: a meta-analysis
Gargya et al. Peripheral nerve stimulator for chronic pain from quadriceps tendon rupture: a case report
Frost Treatment of complex regional pain syndrome type 1 in a pediatric patient using the lidocaine patch 5%: a case report
Elnaggar et al. Differential effects of extracorporeal shockwave therapy and botulinum toxin-A injection on postburn contractures and gait kinematics in burn children
RU2428148C1 (ru) Способ профилактики и лечения дорсопатии позвоночника у врачей-стоматологов
Guilley et al. Femoral nerve inguinal approach versus proximal femoral triangle ap proach for continuous regional analgesia in active rehabilitation after total knee arthroplasty: a prospective, randomised study
Chandak et al. Effects of scooping mobilization and muscle energy technique on pain and range of motion in post-fracture elbow stiffness: A case report
Gloth et al. The role of rehabilitation in managing pain in seniors
RU2239381C1 (ru) Способ лечения дегенеративно-деструктивных заболеваний суставов конечностей и позвоночника
RU2619493C1 (ru) Способ лечения плече-лопаточного периартроза
RU2414258C1 (ru) Способ лечения радикулопатий у мелких животных
US20060182819A1 (en) Soap scent patch and treatment for muscle spasm and pain
JP2009191073A (ja) 脂肪減少用外用剤及び脂肪減少装置
Doyle The effects of various tone-reducing neuromuscular blocks in subjects with lower extremity spasticity or dystonia
CN101166525A (zh) 治疗肌肉痉挛及疼痛的皂味皮肤贴和疗法
CA2734300A1 (en) Heat assisted lidocaine and tetracaine for transdermal analgesia
NZ574231A (en) Transdermal medicament containing cholecalciferol (vitamin D3) for the treatment of pain and inflammation

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20141017